Calibration of MR and PET-MR Imaging Protocols at RIC

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT02249520
Collaborator
(none)
40
1
3
315
0.1

Study Details

Study Description

Brief Summary

This is a protocol to facilitate on-site calibration of the technical aspects of the Siemens Biograph mMR (molecular MR) Positron Emission Tomography-Magnetic Resonance (PET-MR) scanner and the 3T Siemens Vida MR scanner at the Cedars-Sinai Medical Center (CSMC) Biomedical Imaging Research Institute (BIRI) Research Imaging Core after scanner installation. The mMR is a FDA-approved standard clinical device (non-experimental) and will be used in accordance with clearance and approval from the FDA. The Vida is a state-of-the-art FDA approved scanner and will be clinically licensed within a short time.

Condition or Disease Intervention/Treatment Phase
  • Other: PET-MR imaging on Biograph mMR scanner
  • Other: MR-only imaging on Biograph mMR scanner
  • Other: MR imaging on the Siemens Vida 3T MR scanner
N/A

Detailed Description

PET-MR Protocol on the Biograph mMR: This protocol requires the use of a radioisotope. To avoid administering radioisotope solely for the purposes of this calibration, we will recruit 20 patients from the clinical population at the S. Mark Taper Foundation Imaging Center at CSMC who are already receiving an isotope dose for their standard-of-care examination and are willing to be scanned at the Research Imaging Core on the same day right after their clinical exam. Subjects who are having a PET-MR after receiving FDG will have the same body part scanned as they did for clinical testing.

MR-only Protocol on the Biograph mMR:To set up MR-only protocols, we will enroll 20 volunteers for MR-only on the mMR scanner. This is a standard MR scan with no isotope involved. Those volunteers who are participating in the MR-only scan will have major body parts and organs scanned as needed for calibration.

MR imaging on the Siemens Vida 3T scanner: applications training is taking place and we will build clinical protocols in the future

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Calibration of MR and PET-MR Imaging Protocols at the Cedars-Sinai Medical Center (CSMC) Biomedical Imaging Research Institute (BIRI) Research Imaging Core
Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2040
Anticipated Study Completion Date :
Dec 1, 2040

Arms and Interventions

Arm Intervention/Treatment
Other: PET-MR imaging on Biograph mMR scanner

Research PET-MR imaging on Biograph mMR scanner will be conducted immediately following administration of FDG for clinically approved scan. No additional radioisotope will be administered for the research scan.

Other: PET-MR imaging on Biograph mMR scanner
Participants will undergo PET-MR imaging on the Biograph mMR scanner to evaluate the technical aspects of the total acquisition protocol directly post clinical administration of FDG, thus removing the requirement for additional radioisotope.
Other Names:
  • Siemens Biograph mMR
  • molecular imaging
  • PET-MR
  • mMR
  • Other: MR-only imaging on Biograph mMR scanner

    Participants will undergo research MR-only imaging on Biograph mMR scanner.

    Other: MR-only imaging on Biograph mMR scanner
    Participants will undergo MR-only imaging to test the technical aspects of the MR-only protocol on the Biograph mMR scanner. No drug administered.
    Other Names:
  • Siemens Biograph mMR
  • PET-MR
  • Other: MR imaging on the Siemens Vida 3T MR scanner

    Participants will undergo research MR imaging on the Siemens MR scanner

    Other: MR imaging on the Siemens Vida 3T MR scanner
    Participants will undergo MR imaging to test the technical aspects of the MR protocol on the Vida MR scanner
    Other Names:
  • MRI
  • Outcome Measures

    Primary Outcome Measures

    1. composite of measures of organ uptake, maximum target-to-background ratio and maximum standard uptake value as standard with FDG PET for maximum image quality for all standard protocols. [one day]

      The mMR is a FDA-approved standard clinical device (non-experimental) and will be used in accordance with clearance and approval from the FDA. Results obtained from these tests will not be analyzed towards the end point of any study and will solely be used to finalize and calibrate the technical performance of the new scanner. All scans will be visually assessed for technique calibration.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age ≥18 years.

    • For MR-PET calibration: Outpatient undergoing standard-of-care 18FDG-PET at S. Mark Taper Foundation Imaging Center at CSMC

    • For MR-only calibration: Volunteers who are responding to approved advertising to volunteer at the BIRI Research Imaging Core for research MR

    Exclusion Criteria:
    • Age < 18 years

    • Pregnancy

    • Any contraindications to MR imaging.

    • Any contraindication to MRI, including metallic implants (valve replacement, pacemaker, implantable cardiac defibrillator, metallic spine material), intracranial clips, metallic fragments in eyes, and claustrophobia.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cedars-Sinai Medical Center Los Angeles California United States 90048

    Sponsors and Collaborators

    • Cedars-Sinai Medical Center

    Investigators

    • Principal Investigator: Daniel S. Berman, M.D., Cedars-Sinai Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Daniel S. Berman, Principal Investigator/Chief Cardiac Imaging/Nuclear Cardiology, Cedars-Sinai Medical Center
    ClinicalTrials.gov Identifier:
    NCT02249520
    Other Study ID Numbers:
    • 35521
    First Posted:
    Sep 25, 2014
    Last Update Posted:
    Mar 8, 2022
    Last Verified:
    Mar 1, 2022
    Keywords provided by Daniel S. Berman, Principal Investigator/Chief Cardiac Imaging/Nuclear Cardiology, Cedars-Sinai Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 8, 2022